Cancer Vaccine

Thread view:

Enable EMail Alerts

Start New Thread

Thread rating:

Glenn Enoch - 30 Oct 2004 21:24 GMT

I noticed in the NY Times on Friday: the Dendron Corporation announced they
had "extended the lives of men with advanced prostate cancer" with an
experimental vaccine called "Provenge." You can see the article at
http://www.nytimes.com/2004/10/29/business/29drug.html ... The NY Times site
requires registration (but no salesman will call).

Reply to this Message

Stephen Jordan - 30 Oct 2004 22:36 GMT

> I noticed in the NY Times on Friday: the Dendron Corporation announced they
> had "extended the lives of men with advanced prostate cancer" with an
> experimental vaccine called "Provenge." You can see the article at
> http://www.nytimes.com/2004/10/29/business/29drug.html ... The NY Times site
> requires registration (but no salesman will call).

Um, this is not a flame: the correct spelling of the company name
is Dendreon.

Provenge is in a late Phase 3 trial stage for the FDA, and is "on
a fast track." I don't have the details, but the release, natch,
makes it sound promising.

The October 28 press release upon which the NYT article is no
doubt based can be found at Dendreon's website:
http://www.dendreon.com/index.php?flash=true

Regards,

Steve J

Reply to this Message

Steve Kramer - 31 Oct 2004 12:08 GMT

Provenge certainly seems to have medicine on a good track. Whether there is
gold at the end of that rainbow is still to be seen. Some studies come back
with great results while others are rather lame. But, it looks like it
works very well in some cases.

Signature

Prostate Cancer Survivor (so far), not a doctor
PSA 16 10/17/2000 @ 46
Biopsy 11/01/2000 G7 (3+4), T2c
RRP 12/15/2000 G7 (3+4), T3bN0M0
PSA .1 .1 .1 .27 .37 .75
EBRT 05-07/2002 @ 47
PSA .34 .22 .15 .21 .32
Lupron (1 mo) 07/21/2003 @ 48
PSA .07 .05 .06
Lupron (3 mo) 8/03 (48), 12/03, 4/04 (49), 09/04 (50)
non illegitimi carborundum

Reply to this Message